This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Five Prime Therapeutics, Inc., Adimab, LLC. Active years: 2022-2026.
Company Filing History:
3 out of 77 
1 out of 52 
Years Active: 2022-2026
Title: Felicia Kemp: Innovator in Antibody Development
Introduction
Felicia Kemp is a prominent inventor based in San Jose, CA. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic use. With a total of 3 patents, her work focuses on innovative solutions for treating various disorders, including cancer.
Latest Patents
One of Felicia Kemp's latest patents involves B7-H4 antibodies and methods of use thereof. This patent provides antibodies and antigen-binding fragments that specifically bind to human B7-H4, as well as to cynomolgus monkey, mouse, and rat B7-H4. The disclosed antibodies are designed to increase T cell proliferation, enhance interferon-gamma production, and deplete B7-H4 expressing cells through ADCC activity. Additionally, the patent outlines methods for treating disorders such as cancer by administering these specific antibodies.
Career Highlights
Felicia Kemp is currently associated with Five Prime Therapeutics, Inc., where she continues to advance her research in antibody development. Her innovative work has positioned her as a key figure in the biotechnology sector, contributing to the understanding and treatment of complex diseases.
Collaborations
Felicia has collaborated with notable colleagues, including Charles Kaplan and Derrick Houser. These partnerships have further enriched her research and development efforts in the field.
Conclusion
Felicia Kemp's contributions to antibody research and development highlight her role as an influential inventor in biotechnology. Her innovative patents and collaborations continue to pave the way for advancements in medical treatments.